• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    LeddarTech Appoints Chris Stewart as Chief Financial Officer

    11/15/23 12:07:00 AM ET
    $BNGO
    $PRSR
    $TSLA
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Blank Checks
    Finance
    Get the next $BNGO alert in real time by email

    QUEBEC CITY, Canada, Nov. 15, 2023 (GLOBE NEWSWIRE) -- LeddarTech®, an automotive software company that provides patented disruptive low-level sensor fusion and perception software technology for ADAS and AD, proudly announces the appointment of Mr. Chris Stewart as Chief Financial Officer ("CFO").

    As CFO at LeddarTech, Mr. Stewart will be instrumental in supporting LeddarTech in completing its recently announced business combination with Prospector Capital Corp. and transitioning to a publicly traded company.

    Mr. Stewart has over 20 years of financial management experience at companies ranging from startups to large public companies. Mr. Stewart previously served as the Chief Financial Officer of Bionano Genomics Inc. (NASDAQ:BNGO) from September 2020 until joining LeddarTech in November 2023, Head of Maxwell Ultracapacitors at Tesla Inc. (NASDAQ:TSLA) from May 2019 to July 2020 and as Vice President of Finance and Information Technology at Maxwell Technologies Inc., a public energy storage company, from July 2015 to May 2019, at which time the company was acquired by Tesla. In addition, Mr. Stewart held multiple leadership roles, including Vice President of Finance at Entropic Communications and Chief Financial Officer of V-ENABLE Inc. (currently GroundTruth), a leader in targeted mobile advertising.

    Mr. Stewart received his B.S. in Business Administration from the University of Southern California and his M.S. in Industrial Administration from Carnegie Mellon University.

    "I am thrilled to join such a visionary company and work alongside LeddarTech's employees at such an exciting time," stated Mr. Stewart. "I eagerly anticipate forging formidable alliances at all levels, including with LeddarTech's shareholders and its board of directors and leadership team, and support LeddarTech as it works toward completing its business combination and operating as a publicly traded company. I am extremely energized by LeddarTech's accomplishments and look forward to helping it realize all of its potential."

    Mr. Charles Boulanger, CEO of LeddarTech, commented: "I am very pleased that Chris has joined the executive team of LeddarTech as Chief Financial Officer. As an accomplished financial executive with extensive experience in leading and optimizing the financial operations of various organizations, Chris has a strong track record of managing and transforming financial functions to drive profitability and growth. Chris's skill set perfectly aligns with LeddarTech's strategic goals."

    LeddarTech Inc. ("LeddarTech") and Prospector Capital Corp. ("Prospector") (NASDAQ:PRSR, PRSRU, PRSRW))), a Cayman Islands exempted company led by former Qualcomm President Derek Aberle and chaired by former Qualcomm Vice Chairman Steve Altman, are party to a definitive business combination agreement that, upon completion of the business combination, would result in LeddarTech becoming a publicly listed company. Upon closing of the transaction, which is expected during the fourth quarter of 2023, the combined company formed through the business combination, LeddarTech Holdings Inc. ("Newco"), is expected to be listed on NASDAQ under the ticker symbol "LDTC."

    About LeddarTech

    A global software company founded in 2007 and headquartered in Quebec City with additional R&D centers in Montreal, Toronto and Tel Aviv, Israel, LeddarTech develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. LeddarTech's automotive-grade software applies advanced AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for better decision making and safer navigation. This high-performance, scalable, cost-effective technology is available to OEMs and Tier 1-2 suppliers to efficiently implement automotive and off-road vehicle ADAS solutions.

    LeddarTech is responsible for several remote-sensing innovations, with over 150 patent applications (80 granted) that enhance ADAS and AD capabilities. Better awareness around the vehicle is critical in making global mobility safer, more efficient, sustainable and affordable: this is what drives LeddarTech to seek to become the most widely adopted sensor fusion and perception software solution.

    Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

    About Prospector Capital Corp.

    Prospector is a special-purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses with a focus on companies with advanced and highly differentiated solutions for the technology sector. The company is led by a team of experienced investors and executives focused on identifying and investing in high-growth companies with strong management teams and attractive market opportunities. Prospector's securities are traded on NASDAQ under the ticker symbols "PRSR," "PRSRU" and "PRSRW."

    Important Information About the Proposed Transaction and Where to Find It

    In connection with the proposed business combination, Prospector, LeddarTech and Newco will prepare and will file with the SEC the registration statement on Form F-4 (the "Registration Statement"), and Prospector will mail the proxy statement/prospectus contained within the Registration Statement to its shareholders and file other documents regarding the business combination with the SEC. This press release is not a substitute for any proxy statement, registration statement, proxy statement/prospectus or other documents Prospector or Newco may file with the SEC in connection with the business combination. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE REGISTRATION STATEMENT WHEN IT BECOMES AVAILABLE, ANY AMENDMENTS OR SUPPLEMENTS TO THE REGISTRATION STATEMENT AND OTHER DOCUMENTS FILED BY PROSPECTOR OR NEWCO WITH THE SEC IN CONNECTION WITH THE BUSINESS COMBINATION, BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the Registration Statement and other documents filed with the SEC by Prospector or Newco through the website maintained by the SEC at www.sec.gov.

    Forward-Looking Statements

    Certain statements contained in this press release may be considered forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act (which forward-looking statements shall also include forward-looking statements and forward-looking information within the meaning of applicable Canadian securities laws), including, but not limited to, statements regarding the business combination involving Prospector, LeddarTech and Newco, the ability to consummate the business combination and the timing thereof, the anticipated benefits from the business combination, the closing of the private placement financing and expected proceeds therefrom and statements relating to Newco's anticipated strategy, future operations, prospects, objectives and financial projections and other financial metrics. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "anticipate," "plan," "likely," "believe," "estimate," "project," "intend" and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: (i) the risk that the conditions to the closing of the business combination are not satisfied, including the failure to timely or at all obtain shareholder approval for the business combination or the failure to timely or at all obtain any required regulatory clearances, including of the Superior Court of Justice of Québec; (ii) uncertainties as to the timing of the consummation of the business combination and the ability of each of Prospector, LeddarTech and Newco to consummate the business combination; (iii) the possibility that other anticipated benefits of the business combination will not be realized, and the anticipated tax treatment of the business combination; (iv) the occurrence of any event that could give rise to termination of the business combination; (v) the risk that shareholder litigation in connection with the business combination or other settlements or investigations may affect the timing or occurrence of the business combination or result in significant costs of defense, indemnification and liability; (vi) changes in general economic and/or industry-specific conditions; (vii) possible disruptions from the business combination that could harm LeddarTech's business; (viii) the ability of LeddarTech to retain, attract and hire key personnel; (ix) potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties resulting from the announcement or completion of the business combination; (x) potential business uncertainty, including changes to existing business relationships, during the pendency of the business combination that could affect LeddarTech's financial performance; (xi) legislative, regulatory and economic developments; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities and any epidemic, pandemic or disease outbreak (including COVID-19), as well as management's response to any of the aforementioned factors; (xiii) access to capital and financing and LeddarTech's ability to maintain compliance with debt covenants; and (xiv) other risk factors as detailed from time to time in Prospector's reports filed with the SEC, including Prospector's Annual Report on Form 10-K, periodic Quarterly Reports on Form 10-Q, periodic Current Reports on Form 8-K and other documents filed with the SEC, as well as the risk factors to be contained in the Registration Statement. The foregoing list of important factors is not exhaustive. Neither Prospector nor LeddarTech can give any assurance that the conditions to the business combination will be satisfied. Except as required by applicable law, neither Prospector nor LeddarTech undertakes any obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

    No Offer or Solicitation

    This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities of Prospector or Newco, a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the "Securities Act").

    Participants in Solicitation

    Prospector, LeddarTech and Newco, and certain of their respective directors, executive officers and employees, may be deemed to be participants in the solicitation of proxies in connection with the business combination. Information about the directors and executive officers of Prospector can be found in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on March 31, 2023. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the business combination, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the Registration Statement and other relevant materials when they are filed with the SEC. These documents can be obtained free of charge from the source indicated above.

    Contact:

    Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc. Tel.: + 1-418-653-9000 ext. 232 [email protected]

    • Investor relations website: https://investors.LeddarTech.com
    • Investor relations contact: Kevin Hunt, ICR Inc. [email protected]
    • Financial media contact: Dan Brennan, ICR Inc. [email protected]

    Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.



    Primary Logo

    Get the next $BNGO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BNGO
    $PRSR
    $TSLA

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    7/29/2025$319.00 → $325.00Outperform
    RBC Capital Mkts
    Tesla Inc.
    $TSLA
    7/25/2025$349.00Buy → Hold
    China Renaissance
    Tesla Inc.
    $TSLA
    7/24/2025$303.00 → $333.00Buy
    Canaccord Genuity
    Tesla Inc.
    $TSLA
    7/7/2025Outperform → Mkt Perform
    William Blair
    Tesla Inc.
    $TSLA
    6/26/2025$350.00 → $475.00Buy
    The Benchmark Company
    Tesla Inc.
    $TSLA
    6/9/2025$320.00Outperform → Neutral
    Robert W. Baird
    Tesla Inc.
    $TSLA
    6/9/2025Buy → Hold
    Argus
    Tesla Inc.
    $TSLA
    4/21/2025$325.00 → $275.00Equal Weight
    Barclays
    More analyst ratings

    $BNGO
    $PRSR
    $TSLA
    SEC Filings

    View All

    SEC Form 10-Q filed by Bionano Genomics Inc.

    10-Q - Bionano Genomics, Inc. (0001411690) (Filer)

    8/14/25 4:13:27 PM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Bionano Genomics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Bionano Genomics, Inc. (0001411690) (Filer)

    8/14/25 4:04:18 PM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Tesla Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Tesla, Inc. (0001318605) (Filer)

    8/4/25 6:03:14 AM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    $BNGO
    $PRSR
    $TSLA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts reiterated coverage on Tesla with a new price target

    RBC Capital Mkts reiterated coverage of Tesla with a rating of Outperform and set a new price target of $325.00 from $319.00 previously

    7/29/25 8:14:47 AM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    Tesla downgraded by China Renaissance with a new price target

    China Renaissance downgraded Tesla from Buy to Hold and set a new price target of $349.00

    7/25/25 9:00:39 AM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    Canaccord Genuity reiterated coverage on Tesla with a new price target

    Canaccord Genuity reiterated coverage of Tesla with a rating of Buy and set a new price target of $333.00 from $303.00 previously

    7/24/25 7:54:36 AM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    $BNGO
    $PRSR
    $TSLA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gebbia Joseph bought $1,025,232 worth of shares (4,000 units at $256.31) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/28/25 6:45:17 PM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    $BNGO
    $PRSR
    $TSLA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Musk Elon was granted 96,000,000 shares (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    8/4/25 7:00:13 PM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    Director Murdoch James R exercised 90,000 shares at a strike of $17.47 (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    7/15/25 7:30:50 PM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    Chief Financial Officer Taneja Vaibhav exercised 6,000 shares at a strike of $18.22 and sold $1,771,545 worth of shares (6,000 units at $295.26) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    7/9/25 8:12:54 PM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    $BNGO
    $PRSR
    $TSLA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

    SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today reported financial results for the second quarter ended June 30, 2025. "We continued to execute on our new strategy of focusing on our base of routine users of optical genome mapping (OGM) and VIA™ software as the primary drivers of our revenue and gross profit in the second quarter. These routine users are increasingly leveraging our OGM systems and software and we believe the recent upgrades to our software and compute platforms will drive further utilization. I'm very proud of our team for driving gross margin above 50% this quarter, which combined with our continued efforts to reduce costs, gives

    8/14/25 4:01:00 PM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

    SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Institut Necker Enfants Malades (INEM) and colleagues from multiple French pediatric hematology centers showing how optical genome mapping (OGM) can be used to detect oncogenic structural variants (SVs) in clinical research of infant and toddler T-cell acute lymphoblastic leukemia (T-ALL). The publication shows that OGM can reveal distinct genetic drivers and prognostic subgroups that conventional cytogenetics failed to identify in a retrospective, national cohort of 27 T-ALL cases of infants and toddlers (<3 years) as part

    8/7/25 8:00:00 AM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

    SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that Erik Holmlin, PhD, Bionano's president and chief executive officer, will present at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025. Conference & Webcast Details Date:August 13, 2025Time:3:00 p.m. to 3:25 p.m. ETPresenter:Erik Holmlin, PhD, CEO of BionanoWebcast:Link to Register A replay / recording of the session will be available following the conference through the Bionano website at https://ir.bionano.com/ for at least 30 days. About Bionano Bionano is a provider of genome analysis solutions that can enable researchers and clinicians t

    8/6/25 8:00:00 AM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BNGO
    $PRSR
    $TSLA
    Financials

    Live finance-specific insights

    View All

    Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

    SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today reported financial results for the second quarter ended June 30, 2025. "We continued to execute on our new strategy of focusing on our base of routine users of optical genome mapping (OGM) and VIA™ software as the primary drivers of our revenue and gross profit in the second quarter. These routine users are increasingly leveraging our OGM systems and software and we believe the recent upgrades to our software and compute platforms will drive further utilization. I'm very proud of our team for driving gross margin above 50% this quarter, which combined with our continued efforts to reduce costs, gives

    8/14/25 4:01:00 PM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

    SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that it will host a conference call and live webcast on Thursday, August 14, 2025, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2025 and to highlight recent corporate progress. Conference Call & Webcast Details Date:Thursday, August 14th, 2025Time:4:30 p.m. ETParticipant Link:Registration – Click hereWebcast Link:https://edge.media-server.com/mmc/p/tnombut6/ Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano's investor relations website at h

    7/31/25 4:05:00 PM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Tesla Second Quarter 2025 Production, Deliveries & Deployments

    In the second quarter, we produced over 410,000 vehicles, delivered over 384,000 vehicles and deployed 9.6 GWh of energy storage products. Thank you to all our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q2 2025   Production Deliveries Subject to operating lease accounting Model 3/Y 396,835 373,728 2% Other Models 13,409 10,394 7% Total 410,244 384,122 2% Tesla will post its financial results for the second quarter of 2025 after market close on Wednesday, July 23, 2025. At that time, Tesla will issue a brief advisory conta

    7/2/25 9:09:00 AM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    $BNGO
    $PRSR
    $TSLA
    Leadership Updates

    Live Leadership Updates

    View All

    Tesla Releases Results of 2024 Annual Meeting of Stockholders

    Tesla Is Now a Texas Corporation At today's Annual Stockholders' Meeting, Tesla stockholders overwhelmingly approved the ratification of the 2018 CEO Performance Award and the redomestication of the Company to Texas. Tesla has submitted all filings to effectuate its conversion into a Texas corporation and can confirm that the Company is now incorporated in Texas. Full voting results for its 2024 Annual Meeting of Stockholders are below. AGENDA ITEM PROPOSAL BOARD VOTE RECOMMENDATIONS VOTING RESULTS Tesla Proposals 1. A Tesla proposal to elect two Class II directors, James Murdoch and Kimbal Musk, to serve for a term of three years, or until th

    6/13/24 11:10:00 PM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    LeddarTech Appoints Chris Stewart as Chief Financial Officer

    QUEBEC CITY, Canada, Nov. 15, 2023 (GLOBE NEWSWIRE) -- LeddarTech®, an automotive software company that provides patented disruptive low-level sensor fusion and perception software technology for ADAS and AD, proudly announces the appointment of Mr. Chris Stewart as Chief Financial Officer ("CFO"). As CFO at LeddarTech, Mr. Stewart will be instrumental in supporting LeddarTech in completing its recently announced business combination with Prospector Capital Corp. and transitioning to a publicly traded company. Mr. Stewart has over 20 years of financial management experience at companies ranging from startups to large public companies. Mr. Stewart previously served as the Chief Financial

    11/15/23 12:07:00 AM ET
    $BNGO
    $PRSR
    $TSLA
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Blank Checks
    Finance

    Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer

    SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that Gülsen Kama will serve as its next Chief Financial Officer (CFO), effective September 11, 2023. Christopher Stewart, who held the position of CFO since September 2020, will stay on during the transition and then move into an advisory role. Ms. Kama has an extensive background in business planning and execution, especially in operating environments that demand rigorous management of expenses to enable profitable growth. She was most recently Chief Financial Officer at Northern Data AG, where she created and implemented a global finance organization to enable strong growth. Prior to Northe

    8/14/23 8:00:00 AM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BNGO
    $PRSR
    $TSLA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Tesla Inc. (Amendment)

    SC 13G/A - Tesla, Inc. (0001318605) (Subject)

    2/14/24 4:01:18 PM ET
    $TSLA
    Auto Manufacturing
    Consumer Discretionary

    SEC Form SC 13G/A filed by Prospector Capital Corp. (Amendment)

    SC 13G/A - Prospector Capital Corp. (0001825473) (Subject)

    2/13/24 8:46:33 PM ET
    $PRSR
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Bionano Genomics Inc. (Amendment)

    SC 13G/A - Bionano Genomics, Inc. (0001411690) (Subject)

    2/13/24 5:00:51 PM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials